• Wrong document? Swap it for free
  • Written by students who passed
  • Immediately available after payment
  • Read online or as PDF
Sell
Where do you study
Your language
Document preview thumbnail
Preview 4 out of 83 pages
Exam (elaborations)

Wgu D116 Advanced Pharmacology Objective Assessment Practice Exam: 200 Comprehensive Questions With Answers And Rationales For The 2026/2027 Edition

Document preview thumbnail
Preview 4 out of 83 pages

WGU D116 ADVANCED PHARMACOLOGY OBJECTIVE ASSESSMENT PRACTICE EXAM: 200 COMPREHENSIVE QUESTIONS WITH ANSWERS AND RATIONALES FOR THE 2026/2027 EDITION 1. Which of the following best defines pharmacodynamics? A) The study of drug absorption, distribution, metabolism, and excretion. B) The study of what the body does to a drug. C) The study of drug interactions and toxicity. D) The study of what a drug does to the body and its mechanism of action. Correct Answer: D Rationale: Pharmacodynamics is the study of the biochemical and physiological effects of drugs on the body and their mechanisms of action. It is often described as "what the drug does to the body," in contrast to pharmacokinetics, which is "what the body does to the drug." 2. A drug with a high volume of distribution (Vd) is most likely to: A) Remain primarily in the plasma. B) Have a low concentration in tissue. C) Be extensively distributed into tissues. D) Be rapidly excreted by the kidneys. Correct Answer: C Rationale: A high volume of distribution indicates that a drug has extensively distributed into tissues and is not confined to the plasma. Drugs that are highly lipophilic or have extensive tissue binding tend to have a large Vd. 3. A patient with heart failure and decreased cardiac output is prescribed a medication. How does this condition most significantly affect drug distribution? A) It increases drug distribution to the kidneys. B) It has no effect on drug distribution. C) It decreases drug distribution to highly perfused organs like the brain and liver. D) It increases the rate of drug metabolism. Correct Answer: C Rationale: Decreased cardiac output reduces blood flow to highly perfused organs such as the brain, liver, and kidneys. This can significantly alter drug distribution and elimination, potentially leading to higher concentrations in these organs or reduced clearance. 4. A patient is prescribed a medication with a narrow therapeutic index. What is the most important implication for the nurse? A) The drug is safe and requires no monitoring. B) The drug has a wide margin of safety. C) The drug requires close monitoring of serum drug levels for toxicity and efficacy. D) The drug will be effective at any dose. Correct Answer: C Rationale: A narrow therapeutic index means the margin of safety is small; the difference between a therapeutic and a toxic dose is minimal. Therefore, close monitoring of serum drug concentrations is critical to ensure efficacy and avoid toxicity. 5. Which drug is an example of a prodrug that requires CYP2D6 metabolism for activation? A) Warfarin. B) Codeine. C) Lisinopril. D) Furosemide. Correct Answer: B Rationale: Codeine is a prodrug that is converted to its active metabolite, morphine, by the CYP2D6 enzyme. Patients who are poor metabolizers of CYP2D6 will experience reduced analgesic effects. 6. The primary mechanism of action of loop diuretics, such as furosemide, is: A) Blocking aldosterone receptors in the collecting duct. B) Inhibiting the Na⁺-K⁺-2Cl⁻ cotransporter in the thick ascending limb of the loop of Henle. C) Inhibiting carbonic anhydrase in the proximal convoluted tubule. D) Increasing osmotic pressure in the glomerular filtrate. Correct Answer: B Rationale: Loop diuretics are the most potent diuretics. They act on the thick ascending limb of the loop of Henle to inhibit the Na⁺-K⁺-2Cl⁻ cotransporter, preventing electrolyte reabsorption and producing a powerful diuresis. 7. A patient on furosemide therapy complains of muscle cramps and fatigue. The most likely electrolyte imbalance is: A) Hyperkalemia. B) Hypokalemia. C) Hypernatremia. D) Hypercalcemia. Correct Answer: B Rationale: Loop diuretics cause significant potassium wasting in the urine. Hypokalemia can manifest as muscle weakness, cramps, and fatigue and can predispose the patient to cardiac arrhythmias. 8. A patient taking spironolactone, a potassium-sparing diuretic, is prescribed an ACE inhibitor. What is the most significant potential interaction? A) Increased risk of bleeding. B) Increased risk of hyperkalemia. C) Reduced efficacy of the diuretic. D) Increased risk of hypotension. Correct Answer: B Rationale: Spironolactone is a potassium-sparing diuretic that blocks aldosterone, causing the retention of potassium. ACE inhibitors also increase potassium levels. Concurrent use significantly increases the risk of life-threatening hyperkalemia. 9. A patient is started on sacubitril/valsartan (Entresto) for heart failure with reduced ejection fraction (HFrEF). Which statement is correct regarding this medication? A) It is a combination of a beta-blocker and a diuretic. B) It should not be used within 36 hours of an ACE inhibitor due to risk of angioedema. C) It is less effective than an ACE inhibitor alone. D) It is a calcium channel blocker used to reduce blood pressure. Correct Answer: B Rationale: Sacubitril/valsartan is an ARNI (Angiotensin Receptor-Neprilysin Inhibitor). It is a combination drug that has been shown to

Content preview

WGU D116 ADVANCED PHARMACOLOGY OBJECTIVE ASSESSMENT
PRACTICE EXAM: 200 COMPREHENSIVE QUESTIONS WITH ANSWERS
AND RATIONALES FOR THE 2026/2027 EDITION




1. Which of the following best defines pharmacodynamics?
A) The study of drug absorption, distribution, metabolism, and
excretion.
B) The study of what the body does to a drug.
C) The study of drug interactions and toxicity.
D) The study of what a drug does to the body and its mechanism of
action.
Correct Answer: D
Rationale: Pharmacodynamics is the study of the biochemical and
physiological effects of drugs on the body and their mechanisms of
action. It is often described as "what the drug does to the body," in
contrast to pharmacokinetics, which is "what the body does to the
drug."
2. A drug with a high volume of distribution (Vd) is most likely to:
A) Remain primarily in the plasma.
B) Have a low concentration in tissue.
C) Be extensively distributed into tissues.
D) Be rapidly excreted by the kidneys.
Correct Answer: C
Rationale: A high volume of distribution indicates that a drug has
extensively distributed into tissues and is not confined to the plasma.

,Drugs that are highly lipophilic or have extensive tissue binding tend to
have a large Vd.
3. A patient with heart failure and decreased cardiac output is
prescribed a medication. How does this condition most significantly
affect drug distribution?
A) It increases drug distribution to the kidneys.
B) It has no effect on drug distribution.
C) It decreases drug distribution to highly perfused organs like the brain
and liver.
D) It increases the rate of drug metabolism.
Correct Answer: C
Rationale: Decreased cardiac output reduces blood flow to highly
perfused organs such as the brain, liver, and kidneys. This can
significantly alter drug distribution and elimination, potentially leading
to higher concentrations in these organs or reduced clearance.
4. A patient is prescribed a medication with a narrow therapeutic
index. What is the most important implication for the nurse?
A) The drug is safe and requires no monitoring.
B) The drug has a wide margin of safety.
C) The drug requires close monitoring of serum drug levels for toxicity
and efficacy.
D) The drug will be effective at any dose.
Correct Answer: C
Rationale: A narrow therapeutic index means the margin of safety is
small; the difference between a therapeutic and a toxic dose is minimal.
Therefore, close monitoring of serum drug concentrations is critical to
ensure efficacy and avoid toxicity.

,5. Which drug is an example of a prodrug that requires CYP2D6
metabolism for activation?
A) Warfarin.
B) Codeine.
C) Lisinopril.
D) Furosemide.
Correct Answer: B
Rationale: Codeine is a prodrug that is converted to its active
metabolite, morphine, by the CYP2D6 enzyme. Patients who are poor
metabolizers of CYP2D6 will experience reduced analgesic effects.
6. The primary mechanism of action of loop diuretics, such as
furosemide, is:
A) Blocking aldosterone receptors in the collecting duct.
B) Inhibiting the Na⁺-K⁺-2Cl⁻ cotransporter in the thick ascending limb
of the loop of Henle.
C) Inhibiting carbonic anhydrase in the proximal convoluted tubule.
D) Increasing osmotic pressure in the glomerular filtrate.
Correct Answer: B
Rationale: Loop diuretics are the most potent diuretics. They act on the
thick ascending limb of the loop of Henle to inhibit the Na⁺-K⁺-2Cl⁻
cotransporter, preventing electrolyte reabsorption and producing a
powerful diuresis.
7. A patient on furosemide therapy complains of muscle cramps and
fatigue. The most likely electrolyte imbalance is:
A) Hyperkalemia.
B) Hypokalemia.
C) Hypernatremia.
D) Hypercalcemia.

, Correct Answer: B
Rationale: Loop diuretics cause significant potassium wasting in the
urine. Hypokalemia can manifest as muscle weakness, cramps, and
fatigue and can predispose the patient to cardiac arrhythmias.
8. A patient taking spironolactone, a potassium-sparing diuretic, is
prescribed an ACE inhibitor. What is the most significant potential
interaction?
A) Increased risk of bleeding.
B) Increased risk of hyperkalemia.
C) Reduced efficacy of the diuretic.
D) Increased risk of hypotension.
Correct Answer: B
Rationale: Spironolactone is a potassium-sparing diuretic that blocks
aldosterone, causing the retention of potassium. ACE inhibitors also
increase potassium levels. Concurrent use significantly increases the risk
of life-threatening hyperkalemia.
9. A patient is started on sacubitril/valsartan (Entresto) for heart
failure with reduced ejection fraction (HFrEF). Which statement is
correct regarding this medication?
A) It is a combination of a beta-blocker and a diuretic.
B) It should not be used within 36 hours of an ACE inhibitor due to risk
of angioedema.
C) It is less effective than an ACE inhibitor alone.
D) It is a calcium channel blocker used to reduce blood pressure.
Correct Answer: B
Rationale: Sacubitril/valsartan is an ARNI (Angiotensin Receptor-
Neprilysin Inhibitor). It is a combination drug that has been shown to

Document information

Uploaded on
August 9, 2026
Number of pages
83
Written in
2026/2027
Type
Exam (elaborations)
Contains
Questions & answers
$16.99

Wrong document? Swap it for free Within 14 days of purchase and before downloading, you can choose a different document. You can simply spend the amount again.
Written by students who passed
Immediately available after payment
Read online or as PDF

Seller avatar
Reputation scores are based on the amount of documents a seller has sold for a fee and the reviews they have received for those documents. There are three levels: Bronze, Silver and Gold. The better the reputation, the more your can rely on the quality of the sellers work.
maingirose
4.3
(4)
Sold
29
Followers
0
Items
2174
Last sold
4 hours ago



Why students choose Stuvia

Created by fellow students, verified by reviews

Quality you can trust: written by students who passed their tests and reviewed by others who've used these notes.

Didn't get what you expected? Choose another document

No worries! You can instantly pick a different document that better fits what you're looking for.

Pay as you like, start learning right away

No subscription, no commitments. Pay the way you're used to via credit card and download your PDF document instantly.

Student with book image

“Bought, downloaded, and aced it. It really can be that simple.”

Alisha Student

Working on your references?

Create accurate citations in APA, MLA and Harvard with our free citation generator.

Working on your references?

Frequently asked questions